Table 1 Patient baseline characteristics
Characteristics | Overall cohort (N = 142) | ||
|---|---|---|---|
Group H N = 87 (%) | Group HP N = 55 (%) | P-value | |
Age | |||
  ≤ 50 | 47 (54.02) | 31 (56.36) | 0.699 |
  > 50 | 40 (45.98) | 24 (43.64) |  |
Menopausal status | |||
 Premenopausal | 49 (56.32) | 32 (58.18) | 0.758 |
 Postmenopausal | 38 (43.68) | 23 (41.82) | |
cT stage (pre-treatment) | |||
 1 | 7 (8.05) | 5 (9.09) | 0.218 |
 2 | 54 (62.07) | 39 (70.91) | |
 3 | 13 (14.94) | 4 (7.27) | |
 4 | 13 (14.94) | 7 (12.73) | |
HR | |||
 Negative | 38 (43.68) | 26 (47.27) | 0.553 |
 Positive | 49 (56.32) | 29 (52.73) | |
Her2 | |||
 IHC 2 + /FISH +  | 13 (14.94) | 5 (9.4) | 0.149 |
 IHC 3 +  | 74 (85.06) | 50 (90.6) | |
Ki67 | |||
  < 20% | 9 (10.34) | 7 (12.5) | 0.536 |
  ≥ 20% | 78 (89.66) | 48 (87.5) | |